386 related articles for article (PubMed ID: 32723427)
1. Evaluation of K18-
Moreau GB; Burgess SL; Sturek JM; Donlan AN; Petri WA; Mann BJ
Am J Trop Med Hyg; 2020 Sep; 103(3):1215-1219. PubMed ID: 32723427
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function.
Winkler ES; Bailey AL; Kafai NM; Nair S; McCune BT; Yu J; Fox JM; Chen RE; Earnest JT; Keeler SP; Ritter JH; Kang LI; Dort S; Robichaud A; Head R; Holtzman MJ; Diamond MS
Nat Immunol; 2020 Nov; 21(11):1327-1335. PubMed ID: 32839612
[TBL] [Abstract][Full Text] [Related]
3. Comparison of transgenic and adenovirus hACE2 mouse models for SARS-CoV-2 infection.
Rathnasinghe R; Strohmeier S; Amanat F; Gillespie VL; Krammer F; García-Sastre A; Coughlan L; Schotsaert M; Uccellini MB
Emerg Microbes Infect; 2020 Dec; 9(1):2433-2445. PubMed ID: 33073694
[TBL] [Abstract][Full Text] [Related]
4. The K18-Human ACE2 Transgenic Mouse Model Recapitulates Non-severe and Severe COVID-19 in Response to an Infectious Dose of the SARS-CoV-2 Virus.
Dong W; Mead H; Tian L; Park JG; Garcia JI; Jaramillo S; Barr T; Kollath DS; Coyne VK; Stone NE; Jones A; Zhang J; Li A; Wang LS; Milanes-Yearsley M; Torrelles JB; Martinez-Sobrido L; Keim PS; Barker BM; Caligiuri MA; Yu J
J Virol; 2022 Jan; 96(1):e0096421. PubMed ID: 34668775
[TBL] [Abstract][Full Text] [Related]
5. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice.
Bao L; Deng W; Huang B; Gao H; Liu J; Ren L; Wei Q; Yu P; Xu Y; Qi F; Qu Y; Li F; Lv Q; Wang W; Xue J; Gong S; Liu M; Wang G; Wang S; Song Z; Zhao L; Liu P; Zhao L; Ye F; Wang H; Zhou W; Zhu N; Zhen W; Yu H; Zhang X; Guo L; Chen L; Wang C; Wang Y; Wang X; Xiao Y; Sun Q; Liu H; Zhu F; Ma C; Yan L; Yang M; Han J; Xu W; Tan W; Peng X; Jin Q; Wu G; Qin C
Nature; 2020 Jul; 583(7818):830-833. PubMed ID: 32380511
[TBL] [Abstract][Full Text] [Related]
6. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of SARS-CoV-2 in Transgenic Mice Expressing Human Angiotensin-Converting Enzyme 2.
Jiang RD; Liu MQ; Chen Y; Shan C; Zhou YW; Shen XR; Li Q; Zhang L; Zhu Y; Si HR; Wang Q; Min J; Wang X; Zhang W; Li B; Zhang HJ; Baric RS; Zhou P; Yang XL; Shi ZL
Cell; 2020 Jul; 182(1):50-58.e8. PubMed ID: 32516571
[TBL] [Abstract][Full Text] [Related]
8. The lethal K18-hACE2 knock-in mouse model mimicking the severe pneumonia of COVID-19 is practicable for antiviral development.
Zhang Z; Zhou L; Liu Q; Zheng Y; Tan X; Huang Z; Guo M; Wang X; Chen X; Liang S; Li W; Song K; Yan K; Li J; Li Q; Zhang Y; Yang S; Cai Z; Dai M; Xian Q; Shi ZL; Xu K; Lan K; Chen Y
Emerg Microbes Infect; 2024 Dec; 13(1):2353302. PubMed ID: 38753462
[TBL] [Abstract][Full Text] [Related]
9. Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease.
Golden JW; Cline CR; Zeng X; Garrison AR; Carey BD; Mucker EM; White LE; Shamblin JD; Brocato RL; Liu J; Babka AM; Rauch HB; Smith JM; Hollidge BS; Fitzpatrick C; Badger CV; Hooper JW
JCI Insight; 2020 Oct; 5(19):. PubMed ID: 32841215
[TBL] [Abstract][Full Text] [Related]
10. Development of transgenic models susceptible and resistant to SARS-CoV-2 infection in FVB background mice.
Seo SM; Son JH; Lee JH; Kim NW; Yoo ES; Kang AR; Jang JY; On DI; Noh HA; Yun JW; Park JW; Choi KS; Lee HY; Shin JS; Seo JY; Nam KT; Lee H; Seong JK; Choi YK
PLoS One; 2022; 17(7):e0272019. PubMed ID: 35881617
[TBL] [Abstract][Full Text] [Related]
11. Role of neutrophil chemoattractant CXCL5 in SARS-CoV-2 infection-induced lung inflammatory innate immune response in an
Liang Y; Li H; Li J; Yang ZN; Li JL; Zheng HW; Chen YL; Shi HJ; Guo L; Liu LD
Zool Res; 2020 Nov; 41(6):621-631. PubMed ID: 33045777
[TBL] [Abstract][Full Text] [Related]
12. Mouse models of lung-specific SARS-CoV-2 infection with moderate pathological traits.
Kim SH; Kim J; Jang JY; Noh H; Park J; Jeong H; Jeon D; Uhm C; Oh H; Cho K; Jeon Y; On D; Yoon S; Lim SY; Kim SP; Lee YW; Jang HJ; Park IH; Oh J; Seo JS; Kim JJ; Seok SH; Lee YJ; Hong SM; An SH; Kim SY; Kim YB; Hwang JY; Lee HJ; Kim HB; Choi KS; Park JW; Seo JY; Yun JW; Shin JS; Lee HY; Kim K; Lee D; Lee H; Nam KT; Seong JK
Front Immunol; 2022; 13():1055811. PubMed ID: 36457995
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice.
Winkler ES; Chen RE; Alam F; Yildiz S; Case JB; Uccellini MB; Holtzman MJ; Garcia-Sastre A; Schotsaert M; Diamond MS
J Virol; 2022 Jan; 96(1):e0151121. PubMed ID: 34668780
[TBL] [Abstract][Full Text] [Related]
14. A Mouse Model of SARS-CoV-2 Infection and Pathogenesis.
Sun SH; Chen Q; Gu HJ; Yang G; Wang YX; Huang XY; Liu SS; Zhang NN; Li XF; Xiong R; Guo Y; Deng YQ; Huang WJ; Liu Q; Liu QM; Shen YL; Zhou Y; Yang X; Zhao TY; Fan CF; Zhou YS; Qin CF; Wang YC
Cell Host Microbe; 2020 Jul; 28(1):124-133.e4. PubMed ID: 32485164
[TBL] [Abstract][Full Text] [Related]
15. Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2.
Golden JW; Li R; Cline CR; Zeng X; Mucker EM; Fuentes-Lao AJ; Spik KW; Williams JA; Twenhafel N; Davis N; Moore JL; Stevens S; Blue E; Garrison AR; Larson DD; Stewart R; Kunzler M; Liu Y; Wang Z; Hooper JW
mBio; 2022 Feb; 13(1):e0290621. PubMed ID: 35073750
[TBL] [Abstract][Full Text] [Related]
16. Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice.
Thieulent CJ; Dittmar W; Balasuriya UBR; Crossland NA; Wen X; Richt JA; Carossino M
mSphere; 2023 Feb; 8(1):e0055822. PubMed ID: 36728430
[TBL] [Abstract][Full Text] [Related]
17. Kidney and Lung ACE2 Expression after an ACE Inhibitor or an Ang II Receptor Blocker: Implications for COVID-19.
Wysocki J; Lores E; Ye M; Soler MJ; Batlle D
J Am Soc Nephrol; 2020 Sep; 31(9):1941-1943. PubMed ID: 32669323
[No Abstract] [Full Text] [Related]
18. Comparison of model-specific histopathology in mouse models of COVID-19.
Yang S; Cao L; Xu W; Xu T; Zheng B; Ji Y; Huang S; Liu L; Du J; Peng H; Zhang H; Chen J; Ke B; Zheng H; Deng X; Li C; Guo D
J Med Virol; 2022 Aug; 94(8):3605-3612. PubMed ID: 35355296
[TBL] [Abstract][Full Text] [Related]
19. K18-hACE2 mice develop respiratory disease resembling severe COVID-19.
Yinda CK; Port JR; Bushmaker T; Offei Owusu I; Purushotham JN; Avanzato VA; Fischer RJ; Schulz JE; Holbrook MG; Hebner MJ; Rosenke R; Thomas T; Marzi A; Best SM; de Wit E; Shaia C; van Doremalen N; Munster VJ
PLoS Pathog; 2021 Jan; 17(1):e1009195. PubMed ID: 33465158
[TBL] [Abstract][Full Text] [Related]
20. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling.
Israelow B; Song E; Mao T; Lu P; Meir A; Liu F; Alfajaro MM; Wei J; Dong H; Homer RJ; Ring A; Wilen CB; Iwasaki A
J Exp Med; 2020 Dec; 217(12):. PubMed ID: 32750141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]